Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
06/2000
06/29/2000WO2000037639A2 Lymphocytic membrane proteins
06/29/2000WO2000037638A2 Methods and compositions for inhibiting neoplastic cell growth
06/29/2000WO2000037637A1 Novel protein and dna thereof
06/29/2000WO2000037636A1 Socs-box containing peptides
06/29/2000WO2000037634A2 Novel polypeptides and nucleic acids encoding same
06/29/2000WO2000037630A1 Secreted proteins
06/29/2000WO2000037615A1 Recombinant synthesis of beta-lipotropin and other peptides
06/29/2000WO2000037612A1 SOMATIC CELLS WITH ABLATED Prp GENE AND METHODS OF USE
06/29/2000WO2000037610A2 Expression of immunogenic hepatitis b surface antigens in transgenic plants
06/29/2000WO2000037609A2 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
06/29/2000WO2000037503A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
06/29/2000WO2000037502A2 Vascular endothelial cell growth factor antagonists and uses thereof
06/29/2000WO2000037501A1 Removal/purification of serum albumins
06/29/2000WO2000037500A1 Three dimensional structure of a sterile alpha motif domain
06/29/2000WO2000037499A1 Topoisomerase ii inhibitor
06/29/2000WO2000037498A1 THE POLYPEPTIDE DREAM, USED AS Ca2+IONS-DEPENDENT TRANSCRIPTIONAL REGULATOR AND ITS GENE CODING THEREFOR
06/29/2000WO2000037497A1 Sugar transporter and gene encoding the same
06/29/2000WO2000037496A1 Novel fibronectin-binding protein
06/29/2000WO2000037495A1 EF-Tu
06/29/2000WO2000037494A2 Chlamydia trachomatis antigens
06/29/2000WO2000037493A2 Type iii secretion system antigens from bordetella pertussis
06/29/2000WO2000037492A2 Human hepatoma-derived growth factor homologous (huhdgfh) ____
06/29/2000WO2000037491A2 Dnas encoding proteins with signal sequences
06/29/2000WO2000037490A2 Outer surface proteins, their genes, and their use
06/29/2000WO2000037489A2 Fragment of the gylcoprotein cd55/daf for producing highly effective anti-tumour medicaments and method for using the same
06/29/2000WO2000037488A2 Mads-box genes and uses thereof
06/29/2000WO2000037483A1 Protein-protein interactions in neurodegenerative disorders
06/29/2000WO2000037482A2 Peptides and peptide analogues designed from hfe protein and their uses in the treatment of iron overload diseases
06/29/2000WO2000037113A1 11 cby genomic sequence
06/29/2000WO2000037105A2 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
06/29/2000WO2000037104A1 Improved recombinant hepatitis b surface antigen
06/29/2000WO2000037102A2 Improvement of tolerance to a xenograft
06/29/2000WO2000037099A2 Method for accelerating the rate of mucociliary clearance by using a kunitz-type serine protease inhibitor
06/29/2000WO2000037098A1 Shelf-stable formulation of glucagon-like peptide-1
06/29/2000WO2000037094A2 Therapeutic applications of flint polypeptides
06/29/2000WO2000037093A1 Bone resorption inhibitors
06/29/2000WO2000036920A1 Polynucleotide and polypeptide sequences of rabbit g-protein alpha 16
06/29/2000WO2000036919A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
06/29/2000WO2000036910A1 Msh5 ablated mice and uses therefor
06/29/2000WO2000012677A3 Generation of recombinant infectious bursal disease viruses by reverse genetics technology and the use of the recombinant viruses as attenuated vaccines
06/29/2000WO2000012542A3 Cytotoxic lactoferrin derivatives modified by bulky or lipophilic moieties
06/29/2000WO2000012129A3 Salmonella typhi vaccine compositions
06/29/2000WO2000012113A3 Method of modulating memory effector t-cells using a cd2-binding agent, and compositions
06/29/2000WO2000009073A3 Blood-brain barrier therapeutics
06/29/2000WO2000008187A3 Genes involved in tolerance to environmental stress
06/29/2000WO2000008155A3 Human receptor-associated proteins
06/29/2000WO2000008145A3 Novel genes in control of hematopoiesis
06/29/2000WO2000006737A3 Streptococcus pneumoniae proteins and nucleic acid molecules
06/29/2000WO2000006717A3 Improved transformation efficiency in phage display through modification of a coat protein
06/29/2000WO2000006605A3 Heterominibodies
06/29/2000WO2000005373A3 Methods and compositions for the diagnosis and treatment of body weight disorders, including obesity
06/29/2000WO2000002996A3 Recombinant constructs and systems for secretion of proteins via type iii secretion systems
06/29/2000WO2000001817A3 Mammalian genes; dendritic cell prostaglandin-like transponder (dc-pgt), hdtea84, hsljd37r and rankl, hcc5 chemokine, deubiquitinating 11 and 12 (dub11, dub12), md-1, md2 and cyclin e2, related reagents and methods
06/29/2000WO2000001409A3 Porcine circovirus and parvovirus vaccine
06/29/2000WO2000000610A3 Human signal peptide-containing proteins
06/29/2000WO1999067415A9 Novel molecules of the t110-related protein family and uses thereof
06/29/2000WO1999066321A3 Pattern recognition proteins with lectin homology from several animal species and method to use them for measure or modulate innate resistance against bacteria and other pathogenic agents
06/29/2000WO1999066074A9 Vibrio vulnificus molecular probes, antibodies, and proteins
06/29/2000WO1999066028A3 Genes for the biosynthesis of epothilones
06/29/2000WO1999062945A3 Peptide antigens for detection of hiv, hcv and other microbial infections
06/29/2000WO1999055870A3 Transcription and gene expression regulators
06/29/2000WO1999049019A3 Luciferases, fluorescent proteins, nucleic acids encoding the luciferases and fluorescent proteins and the use thereof in diagnostics
06/29/2000WO1999003881A3 Chimeric polypeptide comprising the fragment b of shiga toxin and peptides of therapeutic interest
06/29/2000WO1998059034A3 Treponema pallidum polynucleotides and sequences
06/29/2000DE19954305A1 Peptide des AT¶1¶-Rezeptors und ihre Verwendung, insbesondere für die Diagnostider Präeklampsie Peptides of AT¶1¶ receptor and their use, in particular for pre-eclampsia Diagnostider
06/29/2000DE19909771A1 Substanz zur Gewinnung hochwirksamer Tumorarzneien sowie Verfahren Substance for the production of highly effective tumor drugs and methods
06/29/2000DE19859971A1 New DNA sequence from Sirococcus, useful for detecting fungal pathogens in plants, particularly conifers, by amplification or hybridization
06/29/2000DE19859780A1 Mittel zur Inhibition der Gewebsneubildung Means for inhibiting the formation of tissue
06/29/2000CA2619682A1 Human monoclonal antibodies to ctla-4
06/29/2000CA2450402A1 Methods and compositions for inhibiting cancer cell growth comprising pro224
06/29/2000CA2371289A1 Novel polypeptides and nucleic acids encoding same
06/29/2000CA2359586A1 Orally immunogenic bacterial enterotoxins expressed in transgenic plants
06/29/2000CA2358508A1 Therapeutic applications of flint polypeptides
06/29/2000CA2358086A1 Protein-protein interactions in neurodegenerative disorders
06/29/2000CA2357004A1 Expression of immunogenic hepatitis b surface antigens in transgenic plants
06/29/2000CA2356987A1 Compounds for immunotherapy and diagnosis of colon cancer and methods for their use
06/29/2000CA2356765A1 Bone resorption inhibitors
06/29/2000CA2356764A1 Type iii secretion system antigens from bordetella pertussis
06/29/2000CA2356244A1 Somatic cells with ablated prp gene and methods of use
06/29/2000CA2355968A1 Novel protein and dna thereof
06/29/2000CA2355876A1 Chlamydia trachomatis antigens
06/29/2000CA2355831A1 Novel fibronectin-binding protein
06/29/2000CA2355827A1 Removal/purification of serum albumins
06/29/2000CA2355680A1 Improved recombinant hepatitis b surface antigen
06/29/2000CA2355631A1 Msh5 ablated mice and uses therefor
06/29/2000CA2355402A1 Recombinant synthesis of beta-lipotropin and other peptides
06/29/2000CA2355364A1 Streptococcus pneumoniae proteins and immunogenic fragments for vaccines
06/29/2000CA2355228A1 Bone sialoprotein based toxic gene therapy for the treatment of calcified tumors and tissues
06/29/2000CA2355163A1 Three dimensional structure of a sterile alpha motif domain
06/29/2000CA2355074A1 Lymphocytic membrane proteins
06/29/2000CA2354846A1 Method of enhancing the biological activity of ligands
06/29/2000CA2354843A1 Outer surface proteins, their genes, and their use
06/29/2000CA2354369A1 Complementary dna's encoding proteins with signal peptides
06/29/2000CA2354135A1 Group b streptococcus proteins, and their use
06/29/2000CA2354074A1 Method of identifying a psychotropic agent using differential gene expression
06/29/2000CA2353960A1 Improvement of tolerance to a xenograft
06/29/2000CA2353799A1 Methods and compositions for inhibiting neoplastic cell growth
06/29/2000CA2353775A1 Compositions and methods for the treatment of tumor
06/29/2000CA2352471A1 Compositions and methods for generating monoclonal antibodies representative of a specific cell type
06/28/2000EP1014176A2 Silver halide emulsions containing recombinant gelatin-like proteins
1 ... 2143 2144 2145 2146 2147 2148 2149 2150 2151 2152 2153 2154 2155 2156 2157 2158 2159 2160 2161 2162 2163 ... 2916